Unusual Cervical Spinal Cord Toxicity Associated with Intra-arterial Carboplatin, Intra-arterial or Intravenous Etoposide Phosphate, and Intravenous Cyclophosphamide in Conjunction with Osmotic Blood Brain–Barrier Disruption in the Vertebral Artery

References

1. ↵
   Kroll RA, Neuwelt EA, Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 1998;42:1083-1100

   CrossRefPubMedWeb of Science
2. ↵
   Silbergeld DL, Chicoine MR, Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 1997;86:525-531

   PubMedWeb of Science
3. ↵
   Madajewicz S, Chowhan N, Iliya A, et al. Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors. Cancer 1991;2844-2849
4. ↵
   Markman M, D'Acquisto R, Iannotti N, et al. Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate. J Cancer Res Clin Oncol 1991;117:151-155

   CrossRefPubMedWeb of Science
5. ↵
   Neuwelt EA, Brummett RE, Remsen LG, et al. In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity. Cancer Res 1996;56:706-709

   Abstract/FREE Full Text
6. Neuwalt EA, Brummett RE, Doolittle ND, First evidence of otoprotection against carboplatin-induced hearing loss with a two compartment model in patients with CNS malignancy using sodium thiosulfate. J Pharmacol Exp Ther 1998;286:77-84

   Abstract/FREE Full Text
7. ↵
   Remsen LG, McCormick CI, Sexton G, et al. Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. Neurosurgery 1997;40:1034-1042

   CrossRefPubMed
8. ↵
   Spigelman MK, Zappulla RA, Johnson J, et al. Etoposide-induced blood-brain barrier disruption: effect of drug compared with that of solvents. J Neurosurg 1984;674-678
9. ↵
   Spigelman MK, Zappulla RA, Strauchen JA, et al. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae. Cancer Res 1986;46:1453-1457

   Abstract/FREE Full Text
10. ↵
    Nakajima M, Kashiwagi K, Ohta J, et al. Etoposide induces programmed cell death in neurons cultured from the fetal rat central nervous system. Brain Res 1994;641:350-352

    CrossRefPubMedWeb of Science
11. ↵
    Williams PC, Henner WD, Roman-Goldstein S, et al. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms. Neurosurgery 1995;37:17-28

    PubMedWeb of Science
12. ↵
    Cloughesy TF, Gobin YP, Black KL, et al. Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow. J Neuro Oncol 1997;35:121-131

    CrossRefPubMed
13. Stewart DJ, Belanger JMEG, Grahovac Z, et al. Phase I study of intracarotid administration of carboplatin. Neurosurgery 1992;30:512-517

    PubMedWeb of Science
14. Greco FA, Hainsworth JD, Clinical studies with etoposide phosphate. Semin Oncol 1996;23:45-50

    PubMed
15. Dropcho EJ, Rosenfeld SS, Morawetz RB, et al. Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The Cancer Consortium J Clin Oncol 1992;110:452-458
16. Pfeifle CE, Howell SB, Felthouse RD, et al. High-dose cisplatin with sodium thiosulfate protection. J Clin Oncol 1985;3:237-244

    Abstract
17. ↵
    Goel R, Cleary SM, Horton C, et al. Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin. J Natl Cancer Inst 1989;81:1552-1560

    Abstract/FREE Full Text
18. Elferink F, van der Vijgh WJF, Klein I, Pinedo HM, Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding. Clin Chem 1986;32:641-645

    Abstract/FREE Full Text
19. ↵
    Neuwelt EA, Brummett RE, Remsen LG, et al. In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity. Cancer Res 1996;56:706-709
20. ↵
    Rubinstein R, Gomori MJ, Lossos A, Bokstein F, Chrisin R, Siegal T, Hyperosmolar blood-brain barrier disruption (BBBD) in patients with brain tumors: an in vivo assessment of the window of barrier opening. Neurology 1998;50:A272 (abstr)
21. ↵
    Shapiro WR, Green SB, Burger PC, et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992;76:772-781

    PubMedWeb of Science
22. ↵
    Saris SC, Blasberg RG, Carson RE, Intravascular streaming during carotid artery infusions: demonstration in humans and reduction using diastole-phased pulsatile administration. J Neurosurg 1991;74:763-772

    PubMed
23. Nakagawa H, Fujita T, Kubo S, et al. Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report. Surg Neurol 1994;41:19-27

    CrossRefPubMed
24. ↵
    Mortimer JE, Crowley J, Eyre H, Weiden P, Eltringham J, Stuckey WJ, A phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors. Cancer 1992;69:1220-1223

    PubMed
25. Mahaley SM, Hipp SW, Dropcho EJ, et al. Intracarotid cisplatin chemotherapy for recurrent gliomas. J Neurosurg 1989;70:371-378

    CrossRefPubMedWeb of Science
26. ↵
    Mercier P, Brassier G, Fournier D, et al. Predictability of the cervical origin of the anterior spinal artery. Interv Neuroradiol 1997;3:283-288